دورية أكاديمية
Survival Rate and Prognostic Factors of Localised Prostate Cancer in Southeast Asian Countries: A Systematic Review with Meta-Analysis.
| العنوان: | Survival Rate and Prognostic Factors of Localised Prostate Cancer in Southeast Asian Countries: A Systematic Review with Meta-Analysis. |
|---|---|
| المؤلفون: | Mohammed Nawi A; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia., Masdor NA; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia., Othman R; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia., Kandayah T; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia., Ahmad N; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia., Safian N; Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Cheras, Kuala Lumpur, Malaysia. |
| المصدر: | Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2023 Sep 01; Vol. 24 (9), pp. 2941-2095. Date of Electronic Publication: 2023 Sep 01. |
| نوع المنشور: | Meta-Analysis; Systematic Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Asian Pacific Organization for Cancer Prevention Country of Publication: Thailand NLM ID: 101130625 Publication Model: Electronic Cited Medium: Internet ISSN: 2476-762X (Electronic) Linking ISSN: 15137368 NLM ISO Abbreviation: Asian Pac J Cancer Prev Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Bangkok : Asian Pacific Organization for Cancer Prevention, |
| مواضيع طبية MeSH: | Transurethral Resection of Prostate* , Prostatic Neoplasms*/epidemiology , Prostatic Neoplasms*/therapy , Prostatic Neoplasms*/pathology, Male ; Humans ; Aged ; Survival Rate ; Prognosis ; Southeast Asian People |
| مستخلص: | Prostate cancer (Pca) is one of the most prevalent health conditions affecting men, particularly older men, and cases have increased in recent years. Objective: This review examined the survival rate and prognostic factors of patients with Pca in Southeast Asia (SEA). Methods: We conducted a systematic search of three databases (PubMed, Scopus, Web of Science) and a manual search until April 1, 2022. The selected papers were evaluated using the Newcastle-Ottawa Quality Assessment Form for Cohort Studies. The review protocol was registered with PROSPERO (CRD42022326521). Pooled prevalence rates were calculated using the programme R version 4.2.1. Heterogeneity was assessed using the I2 statistic and p-value. A narrative approach was used to describe prognostic factors. Studies were selected and finalised based on the review question. The quality of the included studies was assessed. Results: A total of 11 studies were included in this review. The 1-, 3-, 5- and 10-year survival rates of SEA Pca cases were 80.8%, 51.9%, 66.1% (range 32.1-100) and 78% (range 55.9-100), respectively. Prognostic factors for Pca were discussed in terms of sociodemographic, disease-related and treatment-related aspects. The predictors of significantly lower survival were age more than 75 years, cancer detected during transurethral resection of the prostate, Gleason score more or equal to eight, high-risk group, metastases and no adjuvant radiotherapy. A meta-analysis on the pooled HR of prostate cancer could not be performed due to the heterogeneity of prognostic factors. The pooled prevalence of localised and metastatic prostate cancer in SEA countries was 39% 95% CI [20-62] and 40% 95% CI [28-53], respectively. Conclusion: The survival rate in SEA countries can be determined by prognostic factors, which can be divided into sociodemographic, disease-related and treatment-related factors. Therefore, further studies are needed to improve the understanding and treatment of Pca in the region SEA. |
| References: | Can Urol Assoc J. 2010 Aug;4(4):243-8. (PMID: 20694099) Ann Acad Med Singap. 2009 Feb;38(2):99-105. (PMID: 19271035) Front Biosci (Elite Ed). 2010 Jan 01;2(2):641-56. (PMID: 20036908) Ann Intern Med. 2017 Oct 03;167(7):449-455. (PMID: 28869989) BMJ Open. 2018 Jan 31;8(1):e019409. (PMID: 29391368) CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338) Curr Med Res Opin. 2016 Oct;32(10):1663-1669. (PMID: 27264113) Eur Urol. 2016 Nov;70(5):862-874. (PMID: 27289567) Cancer Med. 2021 Nov;10(22):8020-8028. (PMID: 34626088) Int J Cancer. 2016 Mar 15;138(6):1388-400. (PMID: 26488767) Cancer Commun (Lond). 2018 Jul 3;38(1):44. (PMID: 29970165) BMC Cancer. 2018 Nov 27;18(1):1175. (PMID: 30482167) Eur Urol. 2020 Jan;77(1):38-52. (PMID: 31493960) Prostate Int. 2013;1(1):16-22. (PMID: 24223397) Eur Urol. 2012 Jun;61(6):1079-92. (PMID: 22424666) Int Urol Nephrol. 2020 Oct;52(10):1885-1891. (PMID: 32476081) BMC Cancer. 2015 May 01;15:338. (PMID: 25929438) BMC Med Res Methodol. 2018 Jan 10;18(1):5. (PMID: 29316881) J Carcinog. 2012;11:7. (PMID: 22529743) Cancer Causes Control. 2008 Mar;19(2):175-81. (PMID: 18027095) Onco Targets Ther. 2017 Jun 12;10:2943-2949. (PMID: 28652776) Ann Glob Health. 2020 Jan 02;86(1):2. (PMID: 31976303) Asian Pac J Cancer Prev. 2013;14(5):3331-5. (PMID: 23803125) Salud Publica Mex. 2016 Apr;58(2):104-17. (PMID: 27557369) Am J Transl Res. 2018 Dec 15;10(12):3877-3886. (PMID: 30662637) Prostate Cancer. 2020 Jan 27;2020:8517130. (PMID: 32411479) Ann Oncol. 2013 Oct;24 Suppl 7:vii11-24. (PMID: 24001758) Prostate Int. 2020 Jun;8(2):62-69. (PMID: 32647642) Int J Urol. 2019 Jan;26(1):83-89. (PMID: 30269369) J Clin Pathol. 2017 Sep;70(9):745-753. (PMID: 28289065) J Med Libr Assoc. 2018 Oct;106(4):531-541. (PMID: 30271302) Cancers (Basel). 2022 Jan 30;14(3):. (PMID: 35158986) Asian J Urol. 2014 Oct;1(1):15-29. (PMID: 29511634) Radiat Oncol. 2019 Apr 25;14(1):60. (PMID: 31018850) Acta Oncol. 2021 Oct;60(10):1291-1295. (PMID: 34259123) Cancer Med. 2021 Nov;10(22):7909-7920. (PMID: 34713977) |
| فهرسة مساهمة: | Keywords: Prognosis; Prostate Cancer; Southeast Asia; survival |
| تواريخ الأحداث: | Date Created: 20230929 Date Completed: 20240105 Latest Revision: 20240105 |
| رمز التحديث: | 20240105 |
| مُعرف محوري في PubMed: | PMC10762736 |
| DOI: | 10.31557/APJCP.2023.24.9.2941 |
| PMID: | 37774044 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2476-762X |
|---|---|
| DOI: | 10.31557/APJCP.2023.24.9.2941 |